ResMed | RMD - Ebit


ResMed reported $505.67M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Ansell USD 146.5M 29.2M Dec/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Cochlear AUD 261.1M 13.9M Dec/2025
Cooper Companies USD -31M 243.8M Mar/2026
CSL USD 2.64B 116M Dec/2025
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fisher Paykel Healthcare NZD 368.8M 70.6M Jun/2026
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 67.4M 13.71M Dec/2025
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Philips EUR 302M 417M Mar/2026
Ramsay Health Care AUD 541.1M 20.7M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Steris USD 318.7M 40.7M Mar/2026
Teleflex USD 37.03M 686K Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026